This content requires a premium subscription.
Please log in or subscribe to continue.
JACC Specialty Journals
JACC: Basic to Translational Science - Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
Released: May 24, 2021
Commentary by Dr. Douglas Mann
JACC: Basic to Translational Science - Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
